- Home
- LITB vs CGTX Comparison
LITB vs CGTX Comparison
Compare LITB & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- CGTX
- Stock Information
- Founded
- LITB 2007
- CGTX 2007
- Country
- LITB Singapore
- CGTX United States
- Employees
- LITB N/A
- CGTX N/A
- Industry
- LITB Catalog/Specialty Distribution
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- CGTX Health Care
- Exchange
- LITB Nasdaq
- CGTX Nasdaq
- Market Cap
- LITB 20.5M
- CGTX 20.5M
- IPO Year
- LITB N/A
- CGTX 2021
- Fundamental
- Price
- LITB $1.22
- CGTX $0.41
- Analyst Decision
- LITB
- CGTX Strong Buy
- Analyst Count
- LITB 0
- CGTX 5
- Target Price
- LITB N/A
- CGTX $5.63
- AVG Volume (30 Days)
- LITB 10.4K
- CGTX 2.0M
- Earning Date
- LITB 08-01-2025
- CGTX 08-07-2025
- Dividend Yield
- LITB N/A
- CGTX N/A
- EPS Growth
- LITB N/A
- CGTX N/A
- EPS
- LITB 0.08
- CGTX N/A
- Revenue
- LITB $231,136,000.00
- CGTX N/A
- Revenue This Year
- LITB N/A
- CGTX N/A
- Revenue Next Year
- LITB N/A
- CGTX N/A
- P/E Ratio
- LITB $14.59
- CGTX N/A
- Revenue Growth
- LITB N/A
- CGTX N/A
- 52 Week Low
- LITB $0.91
- CGTX $0.22
- 52 Week High
- LITB $5.70
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- LITB 51.05
- CGTX 67.18
- Support Level
- LITB $1.11
- CGTX $0.29
- Resistance Level
- LITB $1.25
- CGTX $0.34
- Average True Range (ATR)
- LITB 0.09
- CGTX 0.03
- MACD
- LITB 0.01
- CGTX 0.01
- Stochastic Oscillator
- LITB 60.00
- CGTX 92.43
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.